Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

De novo mutations in ATP1A3 cause alternating hemiplegia of childhood


Alternating hemiplegia of childhood (AHC) is a rare, severe neurodevelopmental syndrome characterized by recurrent hemiplegic episodes and distinct neurological manifestations. AHC is usually a sporadic disorder and has unknown etiology. We used exome sequencing of seven patients with AHC and their unaffected parents to identify de novo nonsynonymous mutations in ATP1A3 in all seven individuals. In a subsequent sequence analysis of ATP1A3 in 98 other patients with AHC, we found that ATP1A3 mutations were likely to be responsible for at least 74% of the cases; we also identified one inherited mutation in a case of familial AHC. Notably, most AHC cases are caused by one of seven recurrent ATP1A3 mutations, one of which was observed in 36 patients. Unlike ATP1A3 mutations that cause rapid-onset dystonia-parkinsonism, AHC-causing mutations in this gene caused consistent reductions in ATPase activity without affecting the level of protein expression. This work identifies de novo ATP1A3 mutations as the primary cause of AHC and offers insight into disease pathophysiology by expanding the spectrum of phenotypes associated with mutations in ATP1A3.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: ATP1A3 mutations and encoded protein modifications associated with AHC and DYT12.
Figure 2: Pedigree of a family with autosomal dominant AHC1.
Figure 3: Effects of disease-causing mutations on protein expression and enzyme activity in COS-7 cells.

Similar content being viewed by others


  1. Verret, S. & Steele, J.C. Alternating hemiplegia in childhood: a report of eight patients with complicated migraine beginning in infancy. Pediatrics 47, 675–680 (1971).

    Article  CAS  Google Scholar 

  2. Bourgeois, M., Aicardi, J. & Goutieres, F. Alternating hemiplegia of childhood. J. Pediatr. 122, 673–679 (1993).

    Article  CAS  Google Scholar 

  3. Mikati, M.A., Kramer, U., Zupanc, M.L. & Shanahan, R.J. Alternating hemiplegia of childhood: clinical manifestations and long-term outcome. Pediatr. Neurol. 23, 134–141 (2000).

    Article  CAS  Google Scholar 

  4. Sweney, M.T. et al. Alternating hemiplegia of childhood: early characteristics and evolution of a neurodevelopmental syndrome. Pediatrics 123, e534–e541 (2009).

    Article  Google Scholar 

  5. Panagiotakaki, E. et al. Evidence of a non-progressive course of alternating hemiplegia of childhood: study of a large cohort of children and adults. Brain 133, 3598–3610 (2010).

    Article  Google Scholar 

  6. Rho, J.M. & Chugani, H.T. Alternating hemiplegia of childhood: insights into its pathophysiology. J. Child Neurol. 13, 39–45 (1998).

    Article  CAS  Google Scholar 

  7. Neville, B.G. & Ninan, M. The treatment and management of alternating hemiplegia of childhood. Dev. Med. Child Neurol. 49, 777–780 (2007).

    Article  CAS  Google Scholar 

  8. Mikati, M.A. et al. A syndrome of autosomal dominant alternating hemiplegia: clinical presentation mimicking intractable epilepsy; chromosomal studies; and physiologic investigations. Neurology 42, 2251–2257 (1992).

    Article  CAS  Google Scholar 

  9. Swoboda, K.J. et al. Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation. Ann. Neurol. 55, 884–887 (2004).

    Article  CAS  Google Scholar 

  10. Bassi, M.T. et al. A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood. J. Med. Genet. 41, 621–628 (2004).

    Article  CAS  Google Scholar 

  11. Vanmolkot, K.R. et al. Novel mutations in the Na+/K+ ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann. Neurol. 54, 360–366 (2003).

    Article  CAS  Google Scholar 

  12. De Fusco, M. et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33, 192–196 (2003).

    Article  CAS  Google Scholar 

  13. Rebhan, M., Chalifa-Caspi, V., Prilusky, J. & Lancet, D. GeneCards: integrating information about genes, proteins and diseases. Trends Genet. 13, 163 (1997).

    Article  CAS  Google Scholar 

  14. de Carvalho Aguiar, P. et al. Mutations in the Na+/K+ ATPase α3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 43, 169–175 (2004).

    Article  Google Scholar 

  15. Anselm, I.A., Sweadner, K.J., Gollamudi, S., Ozelius, L.J. & Darras, B.T. Rapid-onset dystonia-parkinsonism in a child with a novel ATP1A3 gene mutation. Neurology 73, 400–401 (2009).

    Article  CAS  Google Scholar 

  16. Svetel, M. et al. Rapid-onset dystonia-parkinsonism: case report. J. Neurol. 257, 472–474 (2010).

    Article  Google Scholar 

  17. Kamm, C. et al. Novel ATP1A3 mutation in a sporadic RDP patient with minimal benefit from deep brain stimulation. Neurology 70, 1501–1503 (2008).

    Article  CAS  Google Scholar 

  18. Blanco-Arias, P. et al. A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism. Hum. Mol. Genet. 18, 2370–2377 (2009).

    Article  CAS  Google Scholar 

  19. Ogawa, H., Shinoda, T., Cornelius, F. & Toyoshima, C. Crystal structure of the sodium-potassium pump Na+/K+ ATPase with bound potassium and ouabain. Proc. Natl. Acad. Sci. USA 106, 13742–13747 (2009).

    Article  CAS  Google Scholar 

  20. Bellus, G.A. et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am. J. Hum. Genet. 56, 368–373 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Cooper, D.N. & Youssoufian, H. The CpG dinucleotide and human genetic disease. Hum. Genet. 78, 151–155 (1988).

    Article  CAS  Google Scholar 

  22. Clapcote, S.J. et al. Mutation I810N in the α3 isoform of Na+/K+ ATPase causes impairments in the sodium pump and hyperexcitability in the CNS. Proc. Natl. Acad. Sci. USA 106, 14085–14090 (2009).

    Article  CAS  Google Scholar 

  23. Stenson, P.D. et al. Human Gene Mutation Database (HGMD): 2003 update. Hum. Mutat. 21, 577–581 (2003).

    Article  CAS  Google Scholar 

  24. Jain, E. et al. Infrastructure for the life sciences: design and implementation of the UniProt website. BMC Bioinformatics 10, 136 (2009).

    Article  Google Scholar 

  25. Pruitt, K.D. et al. The consensus coding sequence (CCDS) project: identifying a common protein-coding gene set for the human and mouse genomes. Genome Res. 19, 1316–1323 (2009).

    Article  CAS  Google Scholar 

  26. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009).

    Article  CAS  Google Scholar 

  27. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).

    Article  Google Scholar 

  28. Zhu, M. et al. Inferring copy number variants in high-coverage genomes using ERDS. Am. J. Hum. Genet. (in the press).

  29. Ge, D. et al. SVA: software for annotating and visualizing sequenced human genomes. Bioinformatics 27, 1998–2000 (2011).

    Article  CAS  Google Scholar 

Download references


We are deeply indebted to all the AHC-affected families for their participation in this study. We would like to thank the Alternating Hemiplegia of Childhood Foundation (AHCF) for their efforts in coordinating the collection of US samples and the facilitation of US research collaboration. We also would like to thank D. Poncelin (French Family Foundation) and R. Vavassori (Italian AHC Family Foundation) for facilitating the international collaboration.

We thank the Italian Patient Association for Alternating Hemiplegia (AISEA Onlus) for coordinating and funding the project I.B.AHC Biobank and Clinical Registry for Alternating Hemiplegia. Specifically, we thank M.T. Bassi and E. Tenderini for preparing all of the samples from AHC-affected individuals for analysis. Many thanks also to the Scientific Institute E. Medea, which hosts the I.B.AHC Biobank according to the I.B.AHC protocol.

We also thank the ENRAH for the SMEs Consortium, the ENRAH validation committee and all collaborating physicians for the data collection5. We are also grateful to the DNA and cell bank of Genethon for the processing of French blood samples.

The following individuals contributed next-generation sequenced control samples to this study: D. Attix, E. Behr, R. Brown, J. Burke, D. Daskalakis, V. Dixon, Z. Farfel, R. Gbadegesin, A. Holden, E. Holtzman, J. Hoover-Fong, C. Hulette, S. Kerns, D. Lancet, D. Levy, N. Liang, W. Lowe, P. Lugar, D. Marchuk, J. McEvoy, J. Milner, H. Oster, R. Ottman, S. Palmer, E. Pras, V. Shashi, N. Sobriera, D. Valle, K. Welsh-Bohmer and M. Winn, as well as the MURDOCK study community registry. Funding for the collection and sequencing of control samples was provided by the Center for Human Genome Variation, the Center for HIV/AIDS Vaccine Immunology and the Joseph and Kathleen Bryan Alzheimer's Disease Research Center under grants from the National Institutes of Health (NIH), including the National Institute of Allergy and Infectious Disease (UO1AIO67854); the National Institute on Aging (P30 AG028377); the National Institute of Neurological Disorders and Stroke (RC2NS070344 and 1RC2NS070342-01) and the National Institute of Mental Health (RC2MH089915).

This study was funded in part by grants from the AHCF (to K.J.S., S.P.R. and T.M.N.); the ENRAH for SMEs Consortium under the European Commission Sixth Framework Programme; the Institut National de la Santé et de la Recherche Médicale (to S.N. and B.F.); the Centre National de la Recherche Scientifique (to S.N. and B.F.); the University Pierre and Marie Curie (to S.N. and B.F.); the Association Française Contre les Myopathies (to S.N. and B.F.); the Association Française de l'Hémiplégie Alternante (to S.N., A.M.J.M.v.d.M. and B.d.V.); AISEA Onlus (to F.G. and G.N.); the Center for Human Genome Variation; the Wellcome Trust (084730 to S.M.S.); the National Center for Research Resources (UL1RR025764 to the University of Utah Center for Clinical and Translational Sciences; K.J.S.); the NIH (1T32HL105321-01 to C.H.); the University of Luxembourg Institute for Systems Biology Program (to C.H.) and the Center for Medical Systems Biology established in The Netherlands Genomics Initiative and The Netherlands Organisation for Scientific Research (project 050-060-409 to A.M.J.M.v.d.M. and M.D.F.). S.N. is a recipient of a Contrat d'Interface from Assistance Publique-Hôpitaux de Paris.

Author information

Authors and Affiliations




E.L.H., Y.H., S.M.S., M.A.M. and D.B.G. conceived and designed the study. Genetic data were generated and analyzed by E.L.H., K.J.S., Y.H., F.G., S.N., B.d.V., F.D.T., S.F., E.A., L.D.P., C.H., L.B.J., K.V.S., C.E.G., L.L., G.N., A.A. A.M.J.M.v.d.M and D.B.G. DNA samples and phenotypic information for AHC patients were collected, compiled and analyzed by K.J.S., F.G., S.N., N.M.W., B.d.V., F.D.T., B.F., S.H., E.P., M.T.S., T.M.N., L.V., S.P.R., K.J.M., K.S., L.J.P., J.H., M.D.F., A.M.B., G.K.H., C.M.W., D.W., B.J.L., P.U., M.D.K., I.E.S., G.N., A.A., S.M.S., M.A.M., the European AHC Genetics Consortium, the I.B.AHC Consortium and the ENRAH for SMEs Consortium. E.L.H., A.M.J.M.v.d.M., S.M.S., M.A.M. and D.B.G. wrote the paper. All authors reviewed the compiled manuscript.

Corresponding authors

Correspondence to Mohamad A Mikati or David B Goldstein.

Ethics declarations

Competing interests

D.B.G., E.L.H., K.V.S., M.A.M. and Duke University are named on a patent application filed by Duke University on the basis of this work.

Additional information

A full list of members and affiliations appears at the end of this paper.

A full list of members and affiliations appears at the end of this paper.

A full list of members and affiliations appears at the end of this paper.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heinzen, E., Swoboda, K., Hitomi, Y. et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet 44, 1030–1034 (2012).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing